Marktgröße für orale Impfstoffe, Anteilsanalyse bis 2025-2031
Oral Vaccine Market Report Analysis
Oral Vaccine Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Serum Institute of India Pvt. Ltd
- GlaxoSmithKline Plc
- Merck and Co. Inc
- Aventis
- PaxVax Corporation
- VALNEVA Canada Inc
- Janssen Pharmaceuticals
- Shanghai BravoBio Co., Ltd
- Swiss Serum and Vaccine Institute Berne
Regional Overview

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation

- Lebendimpfstoff
- inaktiver Impfstoff
- rekombinanter Impfstoff
- andere

- Polio
- Tollwut
- Tuberkulose
- Grippe
- Atemwegsinfektionen
- HIV
- Sonstige

- Krankenhäuser
- staatliche Impfprogramme
- Forschungsinstitute
- andere

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika